NYU Langone Health | Strategic Alliance Partners
Latest from NYU Langone Health
Educating the Public on the Common Risk Factors for Stroke Awareness: Brandon Giglio, MD
May 25th 2023The director of vascular neurology at NYU Langone Hospital in Brooklyn discussed the high prevalence of common risk factors for stroke, emphasizing the importance of early detection and management for prevention. [WATCH TIME: 4 minutes]
Preserving Cognitive Status in Pediatric Multiple Sclerosis: Kimberly O’Neill, MD
April 24th 2023The pediatric neuroimmunology fellow at NYU Langone provided perspective on a study presented at AAN 2023 comparing cognitive trajectories of pediatric and adult multiple sclerosis. [WATCH TIME: 3 minutes]
Importance of Establishing Healthy Eating Habits in Epilepsy: Orrin Devinsky, MD
March 16th 2023The director of the Comprehensive Epilepsy Center at NYU Langone discussed the importance of healthy eating habits and whether all individuals with epilepsy should consider dieting early in their life. [WATCH TIME: 4 minutes]
Gaining a Better Understanding of Metabolic Changes in Epilepsy From Dieting: Orrin Devinsky, MD
March 12th 2023The director of the Comprehensive Epilepsy Center at NYU Langone provided insight on a recently published study assessing the metabolic effects of short-term modified Atkins diet in patients with epilepsy. [WATCH TIME: 4 minutes]
Antiseizure Agent EQU-001 Shows Safety, Tolerability, and Preliminary Efficacy in Phase 2 Study
January 31st 2023In addition to showing a tolerable safety profile, EQU-001 resulted in reduced IL-17 and IL-1b plasma levels relative to baseline and limited the ability of peripheral mononuclear cells to secrete additional pro-inflammatory cytokines.
XEN1101 Posts Positive Efficacy, Safety in Focal-Onset Epilepsy in Interim Phase 2b Open-Label Data
December 5th 2022The investigational therapy from Xenon Pharmaceuticals showed marked reductions in monthly seizure frequency from months 14 to 20, with consistent safety and good retention rates.
Focal Epilepsy Diagnosis Delay Increases Suicidal Ideation Among Youth
December 4th 2022A retrospective observation study presented as a poster at the 2022 AES annual meeting revealed that youth with focal epilepsy were more at risk for suicidal ideation when there is a delay in receiving a diagnosis.
Using Semiology to Improve Epilepsy Clinical Trials: Jacqueline French, MD
December 3rd 2022The professor of neurology at NYU Grossman School of Medicine and chief medical officer of the Epilepsy Foundation discussed the critical need to ensure the proper classification of seizures when enrolling patients in clinical trials. [WATCH TIME: 4 minutes]
Exponential Growth of Research, Biomarkers in Alzheimer Disease: Thomas Wisniewski, MD
October 19th 2022The director of NYU Langone’s Alzheimer’s Disease Research Center discussed noticeable advancements within the field of Alzheimer disease in recent years and how they contribute to gaining a better understanding of the disease. [WATCH TIME: 5 minutes]
Understanding the Complexity and Heterogenicity of Alzheimer Disease: Thomas Wisniewski, MD
October 11th 2022The director of NYU Langone’s Alzheimer’s Disease Research Center and Center for Cognitive Neurology discussed current knowns and unknowns about the pathology of Alzheimer disease. [WATCH TIME: 4 minutes]
NeuroVoices: Thomas M. Wisniewski, MD, on Raising Awareness for World Alzheimer’s Day
September 21st 2022The director of NYU Langone’s Alzheimer’s Disease Research Center and Center for Cognitive Neurology provided perspective on raising awareness for World Alzheimer’s Day and the ongoing challenges patients with the disease face.
Recommendations for Treating Epilepsy in the Clinical Space: Christopher Elder, MD
September 20th 2022The clinical assistant professor of neurology in the Comprehensive Epilepsy Center at NYU Langone Health gives recommendations for clinical care on prescribed antiseizure medication and RNA therapy. [WATCH TIME: 5 minutes]
The Future of Clinical Care with New Antiseizure Medication: Christopher Elder, MD
September 14th 2022An overview of the shifting landscape of antiseizure medication and various neurostimulation devices is shared by the clinical assistant professor of neurology in the Comprehensive Epilepsy Center at NYU Langone Health. [WATCH TIME: 5 minutes]
The Rise of Neurostimulation in Epilepsy Care: Christopher Elder, MD
September 6th 2022The clinical assistant professor of neurology in the Comprehensive Epilepsy Center at NYU Langone Health shared an overview of the various neurostimulation devices that have made their way into the clinical care of seizure disorders. [WATCH TIME: 4 minutes]
Redefining the Understanding of Alzheimer Disease and Its Pathology: Ralph Nixon, MD, PhD
September 2nd 2022The professor of psychiatry and cell biology at NYU Langone provided commentary on new findings which challenge traditional theories on the root of Alzheimer disease and how it is targeted. [WATCH TIME: 17 minutes]
Recognizing Lysosomal Autophagy as a Realistic Target for Alzheimer Disease: Ralph Nixon, MD, PhD
August 8th 2022The professor of psychiatry and cell biology at NYU Langone pleaded his case for why the Alzheimer community should begin to turn to other drug development strategies, including the relatively young phenomenon of autophagy. [WATCH TIME: 3 minutes]
Using Primseq to Simplify the Complexities of Rehabilitation Intervention Dosing: Heidi Schambra, MD
June 26th 2022The associate professor in the Department of Rehabilitation Medicine at NYU Langone discussed the current methods of prescribing rehabilitation and why a new digital tool can improve them going forward. [WATCH TIME: 3 minutes]
Improving Post-Stroke Rehabilitation Through Primseq Digital Tool: Heidi Schambra, MD
June 24th 2022The associate professor in the Department of Rehabilitation Medicine at NYU Langone provided insight on a recent study that utilized a novel digital tool to track the movement intensity of their stroke rehabilitation. [WATCH NOW: 4 minutes]
